1. Home
  2. ESTC vs STVN Comparison

ESTC vs STVN Comparison

Compare ESTC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elastic N.V.

ESTC

Elastic N.V.

HOLD

Current Price

$78.23

Market Cap

7.9B

Sector

Technology

ML Signal

HOLD

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

HOLD

Current Price

$22.29

Market Cap

7.4B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESTC
STVN
Founded
2012
1949
Country
Netherlands
Italy
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Containers/Packaging
Sector
Technology
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.4B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
ESTC
STVN
Price
$78.23
$22.29
Analyst Decision
Buy
Buy
Analyst Count
28
4
Target Price
$107.38
$25.38
AVG Volume (30 Days)
2.4M
339.1K
Earning Date
11-20-2025
11-06-2025
Dividend Yield
N/A
0.29%
EPS Growth
N/A
19.61
EPS
N/A
0.60
Revenue
$1,609,284,000.00
$1,373,219,524.00
Revenue This Year
$18.25
$8.42
Revenue Next Year
$13.63
$9.52
P/E Ratio
N/A
$36.82
Revenue Growth
16.98
6.97
52 Week Low
$68.10
$17.81
52 Week High
$118.84
$28.00

Technical Indicators

Market Signals
Indicator
ESTC
STVN
Relative Strength Index (RSI) 48.54 39.72
Support Level $73.92 $20.62
Resistance Level $79.87 $23.88
Average True Range (ATR) 2.13 1.11
MACD 0.86 -0.07
Stochastic Oscillator 86.53 11.50

Price Performance

Historical Comparison
ESTC
STVN

About ESTC Elastic N.V.

Elastic is a software company that specializes in AI-search, observability, and security deployments. Its search division offers both traditional keyword search and vector search methods to enable more context-aware querying. The software has open-source origins but generates revenue through valuable add-ons, including simplified data orchestration and server scaling techniques.

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

Share on Social Networks: